Literature DB >> 2181448

Efficient, low-cost protein factories: expression of human adenosine deaminase in baculovirus-infected insect larvae.

J A Medin1, L Hunt, K Gathy, R K Evans, M S Coleman.   

Abstract

Human adenosine deaminase (EC 3.5.4.4), a key purine salvage enzyme essential for immune competence, has been overproduced in Spodoptera frugiperda cells and in Trichoplusia ni (cabbage looper) larvae infected with recombinant baculovirus. The coding sequence of human adenosine deaminase was recombined into a baculovirus immediately downstream from the strong polyhedrin gene promoter. Approximately 60 hr after infection of insect cells with the recombinant virus, maximal levels of intracellular adenosine deaminase mRNA, protein, and enzymatic activity were detected. The recombinant human adenosine deaminase represented 10% of the total cellular protein and exhibited a specific activity of 70 units/mg of protein in crude homogenate. This specific activity is 70-350 times greater than that exhibited by the enzyme in homogenates of the two most abundant natural sources of human adenosine deaminase, thymus and leukemic cells. When the recombinant virus was injected into insect larvae, the maximum recombinant enzyme was produced 4 days postinfection and represented about 2% of the total insect protein with a specific activity of 10-25 units/mg of protein. The recombinant human adenosine deaminase was purified to homogeneity from both insect cells and larvae and demonstrated to be identical to native adenosine deaminase purified from human cells with respect to molecular weight, interaction with polyclonal anti-adenosine deaminase antibody, and enzymatic properties. A pilot purification yielded 8-9 mg of homogeneous enzyme from 22 larvae. The production of large quantities of recombinant human adenosine deaminase in insect larvae is inexpensive and rapid and eliminates the need for specialized facilities for tissue culture. This method should be applicable to large-scale production of many recombinant proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181448      PMCID: PMC53770          DOI: 10.1073/pnas.87.7.2760

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  15 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Purification and subunit structure of adenosine deaminase from human kidney.

Authors:  W P Schrader; A R Stacy
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

3.  Human adenosine deaminase. Distribution and properties.

Authors:  M B Van der Weyden; W N Kelley
Journal:  J Biol Chem       Date:  1976-09-25       Impact factor: 5.157

4.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

5.  Tight-binding inhibitors--IV. Inhibition of adenosine deaminases by various inhibitors.

Authors:  R P Agarwal; T Spector; R E Parks
Journal:  Biochem Pharmacol       Date:  1977-03-01       Impact factor: 5.858

6.  Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  M S Coleman; J Donofrio; J J Hutton; L Hahn; A Daoud; B Lampkin; J Dyminski
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

7.  Immunoaffinity purification and fluorescence studies of human adenosine deaminase.

Authors:  A V Philips; D J Robbins; M S Coleman; M D Barkely
Journal:  Biochemistry       Date:  1987-05-19       Impact factor: 3.162

8.  Adenosine deaminase converts purine riboside into an analogue of a reactive intermediate: a 13C NMR and kinetic study.

Authors:  L C Kurz; C Frieden
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

9.  Purification, characterization and radioimmunoassay of adenosine deaminase from human leukaemic granulocytes.

Authors:  D A Wiginton; M S Coleman; J J Hutton
Journal:  Biochem J       Date:  1981-05-01       Impact factor: 3.857

10.  Human adenosine deaminase. Stoichiometry of the adenosine deaminase-binding protein complex.

Authors:  P E Daddona; W N Kelley
Journal:  Biochim Biophys Acta       Date:  1979-10-24
View more
  10 in total

1.  Downstream processing of insect cell cultures.

Authors:  A R Bernard; M Lusti-Narasimhan; K M Radford; R S Hale; E Sebille; P Graber
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Optimization and validation of recombinant serological tests for African Swine Fever diagnosis based on detection of the p30 protein produced in Trichoplusia ni larvae.

Authors:  D M Pérez-Filgueira; F González-Camacho; C Gallardo; P Resino-Talaván; E Blanco; E Gómez-Casado; C Alonso; J M Escribano
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  Cell lines used for the selection of recombinant baculovirus.

Authors:  J E Maruniak; A Garcia-Canedo; J J Rodrigues
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-04       Impact factor: 2.416

4.  Humoral and in vivo cellular immunity against the raw insect-derived recombinant Leishmania infantum antigens KMPII, TRYP, LACK, and papLe22 in dogs from an endemic area.

Authors:  Felicitat Todolí; Laia Solano-Gallego; Rafael de Juan; Pere Morell; Maria Del Carmen Núñez; Rodrigo Lasa; Silvia Gómez-Sebastián; José M Escribano; Jordi Alberola; Alhelí Rodríguez-Cortés
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

5.  Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family.

Authors:  C Bovolenta; P H Driggers; M S Marks; J A Medin; A D Politis; S N Vogel; D E Levy; K Sakaguchi; E Appella; J E Coligan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Replication inhibition by nucleoside analogues of a recombinant Autographa californica multicapsid nuclear polyhedrosis virus harboring the herpes thymidine kinase gene driven by the IE-1(0) promoter: a new way to select recombinant baculoviruses.

Authors:  F Godeau; C Saucier; P Kourilsky
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

7.  Expression of a functional human adenosine deaminase in transgenic tobacco plants.

Authors:  Sanjeewa Singhabahu; John George; David Bringloe
Journal:  Transgenic Res       Date:  2012-12-21       Impact factor: 2.788

Review 8.  Baculovirus as a highly efficient expression vector in insect and mammalian cells.

Authors:  Yu-chen Hu
Journal:  Acta Pharmacol Sin       Date:  2005-04       Impact factor: 6.150

9.  Rotavirus A-specific single-domain antibodies produced in baculovirus-infected insect larvae are protective in vivo.

Authors:  Silvia Gómez-Sebastián; Maria C Nuñez; Lorena Garaicoechea; Carmen Alvarado; Marina Mozgovoj; Rodrigo Lasa; Alan Kahl; Andres Wigdorovitz; Viviana Parreño; José M Escribano
Journal:  BMC Biotechnol       Date:  2012-09-07       Impact factor: 2.563

10.  Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.

Authors:  Rebecca J Linger; Esther J Belikoff; Ying Yan; Fang Li; Holly A Wantuch; Helen L Fitzsimons; Maxwell J Scott
Journal:  BMC Biotechnol       Date:  2016-03-22       Impact factor: 2.563

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.